Charles Dunn is a Principal at SV Health Investors, focusing on biotech. He helps form and fund companies developing transformational medicines, such as Draig Therapeutics.








At firms with a similar stage, sector and check size.





One email when Charles's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckCharles Dunn is a Principal at SV Health Investors, focusing on biotech. He helps form and fund companies developing transformational medicines, such as Draig Therapeutics.
SV Health Investors has not reported a check size. It invests at pre-seed, seed, series a, series b.
A warm intro from a founder SV Health Investors backed works best.
Last updated 2026-10-15. Is this you? Ask for a correction.